Mereo BioPharma
Mereo BioPharma is an England-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer.
Business Model:
Revenue: $49.2M
Employees: 51-200
Industries / Tags:
Detailed Mereo BioPharma Information
Geographic Data
Address: 1 Cavendish Place
City: London
State: england
Zip: W1G 0QF
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$100M
Raised Total:$194M
Social
Metrics
767,897Website Global Rank
50,645Website Monthly Traffic
Twitter Followers
Description
Mereo BioPharma is an England-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Mereo BioPharma went public on 6/9/2016 on the London Stock Exchange
Listed Exchange:
London Stock Exchange
IPO Date:
6/9/2016
IPO Valuation:
$206M
Ticker Symbol:
MPH
IPO Price:
$2.21/share
Amount Raised:
$22M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
